Skip to main content
ENSG logo

The Ensign Group, Inc. (ENSG) Stock: Price, Forecast & Analyst Target

The Ensign Group, Inc. (ENSG) — MoonshotScore 75/100 (Strong band), calculated Oct 4, 2026. Price $171.78 (+1.27%), as of the Oct 2, 2026 trading session; market cap $10.0B.

Educational signal · not a buy or sell recommendation · How to read this

$171.78 +$2.15 (+1.27%) Market Cap $10.0B

The Ensign Group, Inc. · ENSG · NASDAQ · Healthcare · Medical - Care Facilities

Research dated 2026-09-13: Ensign primarily earns money by delivering skilled nursing and rehabilitation, while a much smaller property operation leases healthcare real estate. The durability of its growth depends on whether care operations can keep expanding profit and cash flow without the rising debt load and recent cash drawdown narrowing financial flexibility.

Price as of Oct 2, 2026

Key Statistics

75 of 100

MoonshotScore v2 · The Ensign Group (ENSG)

Strong
Business Quality Solid (75)
Financial Safety Okay (41)
Valuation Fair (62)
Growth Durability Compounding (96)
Momentum Rising (65)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, though the balance sheet is only middling. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Compounding; Momentum: Rising.

  • quarterly revenue $1.44B (Q2 FY2026, quarter ended Jun 2026)
  • EPS beat 7 of 8
  • Altman Z 3.58 · Piotroski F 7

Helping: business quality, durable growth

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ENSG (29 recorded, newest six shown)
RecordedScoreBand
68Strong
74Strong
75Strong
75Strong
75Strong
75Strong

The score was 75 in the stored Oct 3, 2026 snapshot and remains 75 in the current publication computed Oct 4, 2026 (0).

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$171.78
Change on the day+1.27%
52-week range$141.58–$218.00
Market capitalisation$10.0B
Price / earnings (trailing)26.15
Shares traded on the day356.2K
Beta (volatility vs the S&P 500)0.69

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Sep 5, 2025 to Oct 2, 2026: low $149, high $214, latest $172. $214 $149 high $214 Sep 5, 2025 Oct 2, 2026 · $172 $174Sep 5, 2025$164Sep 19, 2025$175Oct 3, 2025$182Oct 17, 2025$180Oct 31, 2025$178Nov 14, 2025$186Nov 28, 2025$176Dec 12, 2025$176Dec 26, 2025$174Jan 9, 2026$175Jan 23, 2026$198Feb 6, 2026$211Feb 20, 2026$207Mar 6, 2026$200Mar 20, 2026$197Apr 2, 2026$200Apr 17, 2026$184May 1, 2026$178May 15, 2026$168May 29, 2026$149Jun 12, 2026$163Jun 26, 2026$169Jul 10, 2026$173Jul 24, 2026$183Aug 7, 2026$179Aug 21, 2026$171Sep 4, 2026$174Sep 18, 2026$172Oct 2, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for The Ensign Group (ENSG): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Growth Durability Strong
Momentum Moderate
Business Quality Moderate
Financial Safety Neutral
Valuation Moderate

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Sep 20, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Neutral
Revenue Growth Moderate
Debt/Equity Weak
ROE Moderate
Gross Margin Weak

Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Oct 5, 2026, except a card that shows its own read date.

Watch the ENSG film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is The Ensign Group (ENSG), and what does it report?

Short answer · as of

The Ensign Group operates post-acute facilities for patients recovering from serious illness, living with chronic conditions, or needing elder care.

Research dated 2026-09-13.

The Ensign Group operates post-acute facilities for patients recovering from serious illness, living with chronic conditions, or needing elder care. Its offering extends beyond nursing to rehabilitation, lodging, dietary support, senior living, mobile diagnostics, laboratory work and patient transport, so reported revenue measures a broad care-delivery operation rather than property rent alone.

Skilled Services supplies almost all reported revenue. The much smaller Standard Bearer segment represents the property side, making Ensign economically closer to a care operator with supporting real estate than to a healthcare landlord whose tenants generate most of the value.

Sources (as of 2026-09-13): Legal name; Ticker / exchange; Sector / industry (provider taxonomy); Business description; Revenue by segment

2 · Latest results

What do the latest results show for The Ensign Group (ENSG)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $1.44B.

Research dated 2026-09-13.

Revenue has advanced throughout the reported quarterly sequence, while net income and diluted earnings per share have also climbed. Operating profit eased in the latest period despite higher revenue, however, as gross profit increased alongside a marked rise in selling and administrative expense. Because Skilled Services contributes almost all revenue, its economics dominate changes in the consolidated result.

Operating cash flow rebounded sharply from the preceding period and remained comfortably above capital spending. Reported earnings have repeatedly exceeded expectations even when revenue has sometimes fallen short, while management says a continuing shift is already incorporated into its outlook.

Sources (as of 2026-09-13): Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Revenue by segment; Operating cash flow by quarter (USD millions); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Where is operating spending going? — FMP standardized evidence
Period endRevenueR&DSG&AFMP standardized operating result
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
Sep 30, 2025Not availableNot availableNot availableNot available

USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$1.44B$100M$1.68 (diluted)
Q1 FY2026$1.39B$100M$1.67 (diluted)
Q4 FY2025$1.36B$95M$1.61 (diluted)
Q3 FY2025$1.30B$84M$1.42 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for The Ensign Group (ENSG)?

Short answer

Cash and short-term investments were $0.00 at the Jun 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Research dated 2026-09-13.

Ensign is profitable, produces positive operating cash flow and has continued investing in its facilities without consuming all cash generated by operations. Liquidity ratios indicate current assets cover current liabilities, while the available quality and distress screens remain constructive.

The balance sheet still deserves close attention. Debt substantially exceeds cash and investments, and cash and short-term investments dropped sharply in the latest period after declining across the reported window. A sustained combination of weaker facility profitability, heavy capital spending and further cash deployment would reduce the cushion available for operating setbacks or expansion.

Sources (as of 2026-09-13): Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Trailing twelve-month ratio set; Distress and quality screens

4 · What to check next?

What should you watch next at The Ensign Group (ENSG)?

Short answer · as of

Current published price targets run low $202.00 · high $228.00 · consensus $215.00 · median $215.00 against a quoted price of $171.78 (as of Oct 2, 2026).

Research dated 2026-09-13.

Watch whether revenue growth continues to translate into operating-profit growth after the latest divergence, and whether selling and administrative costs settle relative to gross profit. Cash conversion also matters: operating cash flow should remain well ahead of facility investment if Ensign is to rebuild liquidity while carrying substantial debt.

The scheduled earnings release provides a direct test of continued growth expectations and management’s embedded operating shift. Revenue relative to expectations matters, but the recent pattern makes earnings delivery, operating margin and cash generation the more revealing checks.

Sources (as of 2026-09-13): Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions); Cash, investments and debt; Next earnings report; Analyst revenue and earnings estimates (average); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does The Ensign Group compare with its peers?

Short answer

The Ensign Group's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Research dated 2026-09-13.

Ensign combines hands-on post-acute care with supporting property ownership, senior living and mobile clinical services. Pure facility operators lack the same property component, while healthcare landlords depend much more heavily on tenant rent; at Ensign, Skilled Services remains overwhelmingly responsible for revenue, so care delivery rather than real estate valuation drives reported performance.

Sources (as of 2026-09-13): Business description; Revenue by segment; Trailing twelve-month ratio set

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Exelixis, Inc. (EXEL) Named competitor$58.39 Oct 2, 2026$14.7B98 5-pillar Oct 4, 2026
National HealthCare Corporation (NHC) Same industry, near in market value$227.66 Oct 2, 2026$3.56B98 5-pillar Oct 4, 2026
Universal Health Services, Inc. (UHS) Same industry, near in market value$175.72 Oct 2, 2026$10.6B94 5-pillar Oct 4, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$11.83 Oct 2, 2026$4.59B93 5-pillar Oct 4, 2026
Encompass Health Corporation (EHC) Named competitor$119.80 Oct 2, 2026$11.9B89 5-pillar Oct 4, 2026
Tenet Healthcare Corporation (THC) Same industry, near in market value$258.62 Oct 2, 2026$20.8B89 5-pillar Oct 4, 2026
Chemed Corporation (CHE) Same industry, near in market value$507.50 Oct 2, 2026$6.63B87 5-pillar Oct 4, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$22.25 Oct 2, 2026$12.0B84 5-pillar Oct 4, 2026
Align Technology, Inc. (ALGN) Named competitor$143.74 Oct 2, 2026$10.3B83 5-pillar Oct 4, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$22.64 Oct 2, 2026$3.39B81 5-pillar Oct 4, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Same industry, near in market value$12.59 Oct 2, 2026$2.74B81 5-pillar Oct 4, 2026
DaVita Inc. (DVA) Same industry, near in market value$178.69 Oct 2, 2026$11.5B76 5-pillar Oct 4, 2026
The Ensign Group (ENSG) — this page$171.78$10.0B75

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$202.00 – $228.00
Consensus target
$215.00
Median target
$215.00

Consensus record · Captured .

Measured against a quoted price of $171.78 (as of Oct 2, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 10, 2026

Transactions
40
Identified insiders
12
Purchases
0
Sales
8
Other transactions
32

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

What has been published about The Ensign Group (ENSG)?

Read these with our analysis →

The Ensign Group Healthcare Stock: Key Questions Answered

Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.

What does Ensign’s Skilled Services segment actually sell?

It sells short-term and long-term nursing, rehabilitation and related daily support for patients recovering from illness, managing chronic conditions or requiring elder care. This segment supplies almost all company revenue, so occupancy, care activity and realized service revenue have far greater influence than property leasing.

Sources (as of 2026-09-13): Business description; Revenue by segment; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)

Why does Standard Bearer matter to Ensign?

Standard Bearer gives Ensign a property component alongside care operations, but it contributes only a small portion of reported revenue. It broadens the business model without changing the fact that Skilled Services drives consolidated performance.

Sources (as of 2026-09-13): Business description; Revenue by segment

Can Ensign’s cash cover its debt after the recent decline?

Cash and investments cover only a minority of total debt, and cash and short-term investments fell sharply in the latest period. Positive operating cash flow provides support, but rebuilding liquidity depends on cash generation continuing to exceed capital spending and other uses.

Sources (as of 2026-09-13): Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Cash against market value; Operating cash flow by quarter (USD millions)

Is Ensign’s dividend central to the shareholder return profile?

The dividend yield is modest relative to the company’s earnings and cash-flow profile, so the return proposition rests much more on operating growth and valuation than on current income. Recent payments have nevertheless remained consistent, with the latest rate above the earlier payment shown.

Sources (as of 2026-09-13): Recent dividends paid; Dividends per share, last 12 months (split-adjusted); Dividend yield, last 12 months; Trailing twelve-month ratio set

What is the ENSG stock price today?

The last price recorded on this page for The Ensign Group, Inc. (ENSG) is $171.78, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the ENSG price target?

The analyst consensus price target for The Ensign Group, Inc. (ENSG) is $215.00 (range $202.00 to $228.00, median $215.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources (as of 2026-09-13): Business description; Revenue by segment; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and short-term investments over time (USD millions)

Sources — records for every figure on this page (27 figures)

The 27 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

OFFICIAL — 1 fact from SEC filings and earnings calls

OFFICIAL facts used on this page
Fact IDFactValue as shownAs ofTierSource
id.hqSEC filing business address29222 Rancho Viejo RD., Suite 127, SAN Juan Capistrano, CA, 92675OFFICIALSEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "29222 Rancho Viejo Road, San Juan Capistrano, CA, 92675, US".

FMP — 22 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$171.78FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T02:54:44.178Z.
px.changeChange on the day+1.27%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$10.0BFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:01.000Z. Captured from FMP at 2026-10-05T02:54:42.545Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars+$2.15FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$1.44BFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.range5252-week range$141.58–$218.00FMPFinancial Modeling Prep (FMP) quote
px.pePrice / earnings (trailing)26.15FMPFinancial Modeling Prep (FMP) · quote
px.volumeShares traded on the day356.2KFMPFinancial Modeling Prep (FMP) · quote
px.betaBeta0.69FMPFinancial Modeling Prep (FMP) company profile
id.ceoChief executiveBarry R. PortFMPFinancial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it.
id.employeesEmployees46,000FMPFinancial Modeling Prep (FMP) company profile
fin.annualRevenue and net result by fiscal year5 fiscal years, FY1970 through FY2025: FY1970 revenue $0.00, net result $0.00; FY2022 revenue $0.00, net result $0.00; FY2023 revenue $0.00, net result $0.00; FY2024 revenue $0.00, net result $0.00; FY2025 revenue $0.00, net result $0.00FMPFinancial Modeling Prep (FMP), from the company's 10-K income statements
fin.gross_marginGross margin (trailing twelve months)16.6%FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero.
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed
fin.cash_investmentsCash and short-term investments$0.00FMPFinancial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. The market-value ratio is undefined when the reported amount is zero.
fin.total_debtTotal debt$0.00FMPFinancial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability.
fin.price_to_bookPrice to book value4.07×FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero.
earn.ptStored analyst price targetslow $202.00 · high $228.00 · consensus $215.00 · median $215.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_rangeAnalyst price target, low to high$202.00 – $228.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_consensusConsensus analyst price target$215.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
earn.pt_medianMedian analyst price target$215.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied
own.insidersInsider transactions via FMP40 transactions · 0 purchases, 8 sales, 32 other transactions · 12 identified insiders · of the newest 100 records, those within the last 180 days, newest dated Sep 10, 2026FMPFinancial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

UNRECORDED — 2 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.historyReported versus estimated, recent quartersEPS beat 7 of 8UNRECORDEDStored earnings-history observation — Captured 2026-10-04
fin.scoresDistress and quality screensAltman Z 3.58 · Piotroski F 7UNRECORDEDStored financial-scores observation — Captured 2026-10-03 · Expired observation

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v275 of 100 · Strong · pillars 75 / 41 / 62 / 96 / 65OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement75 (stored snapshot Oct 3, 2026) → 75 (current publication computed Oct 4, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots
Published
Research standards
Methodology · Editorial policy · Corrections

Sources used for research written 2026-09-13

Historical evidence preserved with this analysis. Current figures are listed separately above.

EvidenceCaptured valueSource dateSource typeSource
Business description
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.
2026-09-13FMPFinancial Modeling Prep (FMP) company profile
Revenue by segment
Standard Bearer Segment: $126.93M; Skilled Services Segment: $4.84B
2025-12-31FMPFinancial Modeling Prep (FMP) revenue segmentation, from the company's 10-K
Quarterly income statement (USD thousands)
Captured record · 8 entries
  • Quarter ended 2026-06-30 — EPS: $1.68 per share, SG&A: $85.92M, EPS basic: $1.72 per share, EPS basis: diluted, Revenue: $1.44B, EPS diluted: $1.68 per share, Net result: $99.74M, Gross profit: $239.83M, Operating result: $122.50M
  • Quarter ended 2026-03-31 — EPS: $1.67 per share, SG&A: $74.21M, EPS basic: $1.73 per share, EPS basis: diluted, Revenue: $1.39B, EPS diluted: $1.67 per share, Net result: $99.67M, Gross profit: $227.86M, Operating result: $124.85M
  • Quarter ended 2025-12-31 — EPS: $1.61 per share, SG&A: $70.79M, EPS basic: $1.66 per share, EPS basis: diluted, Revenue: $1.36B, EPS diluted: $1.61 per share, Net result: $95.45M, Gross profit: $118.00M, Operating result: $123.81M
  • Quarter ended 2025-09-30 — EPS: $1.42 per share, SG&A: $67.37M, EPS basic: $1.46 per share, EPS basis: diluted, Revenue: $1.30B, EPS diluted: $1.42 per share, Net result: $83.84M, Gross profit: $190.22M, Operating result: $96.22M
  • Quarter ended 2025-06-30 — EPS: $1.44 per share, SG&A: $69.11M, EPS basic: $1.48 per share, EPS basis: diluted, Revenue: $1.23B, EPS diluted: $1.44 per share, Net result: $84.40M, Gross profit: $198.79M, Operating result: $103.90M
  • Quarter ended 2025-03-31 — EPS: $1.37 per share, SG&A: $62.55M, EPS basic: $1.41 per share, EPS basis: diluted, Revenue: $1.17B, EPS diluted: $1.37 per share, Net result: $80.28M, Gross profit: $188.12M, Operating result: $101.37M
  • Quarter ended 2024-12-31 — EPS: $1.36 per share, SG&A: $55.61M, EPS basic: $1.4 per share, EPS basis: diluted, Revenue: $1.13B, EPS diluted: $1.36 per share, Net result: $79.69M, Gross profit: $178.91M, Operating result: $100.78M
  • Quarter ended 2024-09-30 — EPS: $1.34 per share, SG&A: $56.18M, EPS basic: $1.38 per share, EPS basis: diluted, Revenue: $1.08B, EPS diluted: $1.34 per share, Net result: $78.44M, Gross profit: $166.99M, Operating result: $89.34M
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements
Operating cash flow by quarter (USD millions)
Captured record · 8 entries
  • Quarter ended 2026-06-30 — Capital expenditure: -$52.83M, Operating cash flow: $171.95M
  • Quarter ended 2026-03-31 — Capital expenditure: -$35.47M, Operating cash flow: $100.15M
  • Quarter ended 2025-12-31 — Capital expenditure: -$49.84M, Operating cash flow: $183.32M
  • Quarter ended 2025-09-30 — Capital expenditure: -$51.19M, Operating cash flow: $153.00M
  • Quarter ended 2025-06-30 — Capital expenditure: -$49.59M, Operating cash flow: $155.73M
  • Quarter ended 2025-03-31 — Capital expenditure: -$42.93M, Operating cash flow: $72.22M
  • Quarter ended 2024-12-31 — Capital expenditure: -$48.16M, Operating cash flow: $100.46M
  • Quarter ended 2024-09-30 — Capital expenditure: -$45.44M, Operating cash flow: $134.48M
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements
Cash, investments and debt
Total debt: $2.25B; Liquidity basis: cash and short-term investments; Total liabilities: $3.30B; Cash and short-term investments: $320.84M; Cash and investments: $530.90M; Long-term investments: $210.08M; Long-term investments classification: unclassified

Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability.

2026-06-30FMPFinancial Modeling Prep (FMP), from the company's balance sheet
Cash and short-term investments over time (USD millions)
Captured record · 8 entries
  • 2026-06-30 — Amount: $320.80M, Cash basis: cash and short-term investments
  • 2026-03-31 — Amount: $595.20M, Cash basis: cash and short-term investments
  • 2025-12-31 — Amount: $572.40M, Cash basis: cash and short-term investments
  • 2025-09-30 — Amount: $506.30M, Cash basis: cash and short-term investments
  • 2025-06-30 — Amount: $418.40M, Cash basis: cash and short-term investments
  • 2025-03-31 — Amount: $344.50M, Cash basis: cash and short-term investments
  • 2024-12-31 — Amount: $526.90M, Cash basis: cash and short-term investments
  • 2024-09-30 — Amount: $571.00M, Cash basis: cash and short-term investments
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's quarterly balance sheets
Legal name
ENSIGN GROUP, INC

Our market-data provider lists the name as "The Ensign Group, Inc."; the filer's own record is used here.

2026-02-04OFFICIALSEC EDGAR — 10-K filed 2026-02-04
Ticker / exchange
ENSG on Nasdaq
2026-09-13OFFICIALSEC EDGAR filer record
Sector / industry (provider taxonomy)
Healthcare / Medical - Care Facilities

The company's SEC filings classify it under SIC 8051 — Services-Skilled Nursing Care Facilities.

2026-09-13FMPFinancial Modeling Prep (FMP) company profile
Annual revenue and net result (USD millions)
Captured record · 5 entries
  • FY2025 — R&D: $0, Revenue: $5.06B, Period end: 2025-12-31, Net result: $343.97M
  • FY2024 — R&D: $0, Revenue: $4.26B, Period end: 2024-12-31, Net result: $297.97M
  • FY2023 — R&D: $0, Revenue: $3.73B, Period end: 2023-12-31, Net result: $209.40M
  • FY2022 — R&D: $0, Revenue: $3.03B, Period end: 2022-12-31, Net result: $224.68M
  • FY2021 — R&D: $0, Revenue: $2.63B, Period end: 2021-12-31, Net result: $194.65M
2025-12-31FMPFinancial Modeling Prep (FMP), from the company's 10-K income statements
Reported versus estimated, last 8 quarters
Captured record · 8 entries
  • Reported 2026-07-27 — EPS actual: $1.92 per share, EPS estimated: $1.8 per share, Revenue actual: $1.44B, Revenue estimated: $1.44B
  • Reported 2026-04-30 — EPS actual: $1.85 per share, EPS estimated: $1.82 per share, Revenue actual: $1.39B, Revenue estimated: $1.40B
  • Reported 2026-02-04 — EPS actual: $1.82 per share, EPS estimated: $1.75 per share, Revenue actual: $1.36B, Revenue estimated: $1.37B
  • Reported 2025-11-03 — EPS actual: $1.64 per share, EPS estimated: $1.59 per share, Revenue actual: $1.30B, Revenue estimated: $1.37B
  • Reported 2025-07-24 — EPS actual: $1.59 per share, EPS estimated: $1.55 per share, Revenue actual: $1.23B, Revenue estimated: $1.22B
  • Reported 2025-04-29 — EPS actual: $1.52 per share, EPS estimated: $1.49 per share, Revenue actual: $1.17B, Revenue estimated: $1.17B
  • Reported 2025-02-05 — EPS actual: $1.49 per share, EPS estimated: $1.47 per share, Revenue actual: $1.13B, Revenue estimated: $1.13B
  • Reported 2024-10-24 — EPS actual: $1.39 per share, EPS estimated: $1.38 per share, Revenue actual: $1.08B, Revenue estimated: $1.07B
2026-07-27FMPFinancial Modeling Prep (FMP) earnings
Management outlook — dated call excerpts
Captured record · 1 entry
  • Call of 2026-07-28 — Quote: And if -- the continued shift is baked into our guidance for Q3, Q4., Speaker: Suzanne Snapper

Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording.

2026-07-28OFFICIALCompany earnings call, transcript via Financial Modeling Prep (FMP)
Cash and investment components
Total basis: cash short and long-term investments; Total: $530.90M; Cash and short-term investments: $320.80M; Long-term investments: $210.10M; Long-term investments classification: unclassified

Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures.

2026-06-30COMPUTEDComputed from the balance sheet
Cash decline over the reported window
To: 2026-06-30; From: 2024-09-30; Periods: 7; Cash basis: cash and short-term investments; Closing balance: $320.80M; Decline: $250.20M; Opening balance: $571.00M; Average change per period: $35.70M

Change in cash, cash equivalents and short-term investments between the 2024-09-30 and 2026-06-30 balance sheets.; This is a balance change, not operating burn: financing and investing move it too.; Averaged over 7 reporting periods of unequal length.

2026-06-30COMPUTEDComputed from reported balances
Cash against market value
As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$1.93B; Total debt: $2.25B; Cash and investments: $320.80M

Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them.

2026-06-30COMPUTEDComputed from the balance sheet and the latest market capitalization
Trailing twelve-month ratio set
Quick ratio: 1.21; Current ratio: 1.21; Debt to equity: 0.92; Net margin: 6.9%; Gross margin: 14.1%; Operating margin: 8.5%; Return on assets: 6.6%; Return on equity: 16.5%

Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero.

2026-09-13FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm
Distress and quality screens
Altman Z-score: 3.6; Piotroski F-score: 7

Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading.

2026-09-13FMPFinancial Modeling Prep (FMP) financial scores
Next earnings report
Date: 2026-11-02; EPS estimate: $1.94 per share; Revenue estimate: $1.51B

The date is our provider's estimate until the company confirms it.

2026-09-13FMPFinancial Modeling Prep (FMP) earnings calendar
Analyst revenue and earnings estimates (average)
Captured record · 4 entries
  • FY2025 — EPS average: $6.52 per share, Revenue average: $5.06B, Revenue low: $5.05B, Revenue high: $5.11B, Analysts (revenue): 4
  • FY2026 — EPS average: $7.79 per share, Revenue average: $5.90B, Revenue low: $5.89B, Revenue high: $5.91B, Analysts (revenue): 4
  • FY2027 — EPS average: $8.55 per share, Revenue average: $6.51B, Revenue low: $6.42B, Revenue high: $6.58B, Analysts (revenue): 4
  • FY2028 — EPS average: $9.36 per share, Revenue average: $7.10B, Revenue low: $7.02B, Revenue high: $7.21B, Analysts (revenue): 3
2026-09-13FMPFinancial Modeling Prep (FMP) analyst estimates
Most recent periodic reports2026-07-27OFFICIALSEC EDGAR filer submissions
Recent dividends paid
Captured record · 4 entries
  • Ex date: 2026-06-30, Payment date: 2026-07-31, Amount per share: $0.07
  • Ex date: 2026-03-31, Payment date: 2026-04-30, Amount per share: $0.07
  • Ex date: 2025-12-31, Payment date: 2026-01-31, Amount per share: $0.07
  • Ex date: 2025-09-30, Payment date: 2025-10-31, Amount per share: $0.06

Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here.

2026-06-30FMPFinancial Modeling Prep (FMP) dividend history
Dividends per share, last 12 months (split-adjusted)
$0.26

Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-09-13, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate.

2026-06-30COMPUTEDFinancial Modeling Prep (FMP) split-adjusted dividend history
Dividend yield, last 12 months
0.15%

Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate.

2026-09-11COMPUTEDFinancial Modeling Prep (FMP) split-adjusted dividend history and quote
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

ETFs that hold ENSG

Funds in our ETF coverage that list ENSG among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
Amplify COWS Covered Call ETF (HCOW)3.14%
XHS ETF2.44%
IVSS ETF2.01%
Deepwater Beachfront Small Cap ETF (DBSC)2.00%
First Trust SMID Capital Strength ETF (FSCS)1.16%
iShares Russell 2000 Growth ETF (IWO)0.77%
SPDR S&P 600 Small Cap ETF (SLY)0.57%